Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, Daniela Pastore, Angelantonio Maglio, Giovanna Lucia Piazzetta, Nadia Lobello, Nicola Lombardo, Alessandro Vatrella & Girolamo Pelaia. (2024) Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?. Pragmatic and Observational Research 15, pages 45-51.
Read now
Read now
Articles from other publishers (2)
Ibrahim M Dighriri, Anas I Alnughaythir, Amna A Albesisi, Danya I Alhuwaimel, Alanoud S Alotaibi, Laila A Alghowaidi, Fatimah H Almalki, Jasmine N Al-Bukhari, Tahani R Alshammari, Fahad H Alwathnani, Abdulmohsen A Alghamdi, Ali A Alghamdi, Safar D Alshehri, Nora Y Mahnashi & Hassan A Abu Jamilah. (2023) Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review. Cureus.
Crossref
Crossref
Laura Bergantini, Tommaso Pianigiani, Miriana d’Alessandro, Sara Gangi, Behar Cekorja, Elena Bargagli & Paolo Cameli. (2023) The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma. Biomedicine & Pharmacotherapy 166, pages 115385.
Crossref
Crossref